tegafur has been researched along with nedaplatin in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (32.26) | 29.6817 |
2010's | 21 (67.74) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azegami, T; Fujimori, S; Kobayashi, H; Koike, T; Kurashina, K; Kurita, H; Ohtsuka, A; Tanaka, K | 1 |
Furukawa, M; Kawano, T; Komatsu, M; Kubota, A | 1 |
Abiko, R; Akasaka, H; Fujita, K; Hoshikawa, Y; Inaba, H; Itoh, F; Katoh, N; Kimura, M; Kitajima, S; Kobayashi, M; Koro, T; Miyazaki, A; Nakaya, S; Ogihara, K; Okamoto, M; Tsuda, T; Watanabe, Y; Yamauchi, S | 1 |
Fujii, M | 1 |
Asano, R; Iida, M; Kadokura, Y; Katsuno, M; Kobayashi, S; Kubota, H; Morimoto, M; Sanbe, T; Tachibana, S; Takemura, H | 1 |
Ando, T; Maruoka, Y; Ogiuchi, H; Ogiuchi, Y | 1 |
Goto, S; Hatanaka, N; Hirose, M; Itoi, H; Kamiyama, J; Kubota, T; Matsumura, A; Okamoto, K; Otsuji, E; Oyamada, Y; Sakurai, K; Taiyoh, H | 1 |
Iida, M; Tokairin, Y; Yamazaki, S | 1 |
Chen, XB; Fan, QX; Geng, L; Han, JW; Jiao, ZM; Lu, P; Lu, SP; Lu, TY; Luo, SX; Ma, ZY; Song, M; Wang, GJ; Wang, JS; Wang, R; Wang, RL; Wu, XA; Zhang, MZ; Zhao, YF | 1 |
Furuya, A; Kaburagi, A; Kamakazu, K; Kobayashi, S; Monden, T; Mori, T; Ono, T; Sanbe, T; Shimane, T; Suzaki, H | 3 |
Egawa, S; Furuya, A; Kobayashi, S; Mori, T; Ono, T; Sanbe, T; Shimane, T; Suzaki, H | 1 |
Egawa, S; Furuya, A; Kaburagi, A; Kamakazu, K; Kobayashi, S; Mori, T; Ono, T; Sanbe, T; Shimane, T; Suzaki, H | 1 |
Morimoto, M; Sanbe, T; Suzaki, H; Suzuki, T; Takemura, H; Yui, T | 1 |
Karaho, T; Kogashiwa, Y; Kohno, N; Maruyama, T; Matsuda, T; Nagafuji, H; Tsubosaka, T; Yamauchi, K | 1 |
Murai, M; Ohashi, T; Ohnishi, M; Tanahashi, S | 1 |
Egawa, S; Kamakazu, K; Kobayashi, S; Mori, T; Ono, T; Sanbe, T; Shimane, T | 1 |
Akiyama, R; Egawa, S; Hayashi, T; Ikeda, K; Ikenoya, Y; Kobayashi, S; Sanbe, T; Shimane, T; Sugimoto, A; Uzuki, A | 1 |
Akiyama, R; Egawa, S; Hayashi, T; Ikeda, K; Ikenoya, Y; Sanbe, T; Shimane, T; Sugimoto, A; Uzuki, A | 1 |
Osada, S; Takahashi, T; Tanaka, Y; Yamaguchi, K; Yoshida, K | 1 |
Asano, K; Betsuyaku, T; Ikemura, S; Naoki, K; Ogura-Tomomatsu, H; Sato, T; Soejima, K; Terai, H | 1 |
Kobayashi, R; Nakagawa, K; Ohtomo, K; Okuma, K; Shiraishi, K; Yamashita, H | 1 |
Doi, K; Fujisaka, Y; Hayashi, H; Kawakami, H; Nakagawa, K; Nishimura, Y; Nishina, S; Okamoto, I; Okamoto, K; Satoh, T; Takeda, M; Tanaka, K; Terao, K; Ueda, S | 1 |
Kogashiwa, Y; Kohno, N; Sato, D; Tsukahara, K; Yamauchi, K | 1 |
Shi, L; Tang, Y; Teng, XZ; Wang, W | 1 |
Akiyama, K; Hoshikawa, H; Inamoto, R; Indo, K; Kishino, T; Miyashita, T; Mori, N; Mori, T | 1 |
Haga, A; Kiritoshi, T; Nakagawa, K; Ohtomo, K; Okuma, K; Takenaka, R; Yamashita, H | 1 |
Matsuhashi, N; Okumura, N; Tanahashi, T; Tanaka, Y; Yamaguchi, K; Yoshida, K | 1 |
Liu, L; Liu, P; Lou, P; Lv, T; Ou, D; Qin, S; Wang, X; Wang, Y | 1 |
Ohashi, T; Ohnishi, M; Okuda, H; Takada, N; Takagi, C; Takahashi, H | 1 |
1 review(s) available for tegafur and nedaplatin
Article | Year |
---|---|
[A case of elderly advanced squamous cell lung carcinoma successfully treated with nedaplatin and S-1 combination chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Combinations; Humans; Lung Neoplasms; Male; Neoplasm Staging; Organoplatinum Compounds; Oxonic Acid; Tegafur; Tomography, X-Ray Computed | 2012 |
8 trial(s) available for tegafur and nedaplatin
Article | Year |
---|---|
[Clinical phase trial of concurrent chemoradiotherapy combined TS-1 and nedaplatin].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds; Oxonic Acid; Pyridines; Radiotherapy Dosage; Tegafur | 2005 |
Phase I study of S-1 plus nedaplatin in patients with advanced/recurrent head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Disease Progression; Drug Combinations; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Organoplatinum Compounds; Oxonic Acid; Squamous Cell Carcinoma of Head and Neck; Tegafur | 2010 |
Docetaxel, nedaplatin, and S-1 (DGS) chemotherapy for advanced esophageal carcinoma: a phase I dose-escalation study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxonic Acid; Taxoids; Tegafur; Tomography, X-Ray Computed | 2011 |
Phase I pharmacokinetic study of S-1 granules and nedaplatin for advanced head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxonic Acid; Tegafur | 2013 |
Phase I study of nedaplatin prior to S-1 in patients with locally advanced head and neck squamous cell carcinoma.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Organoplatinum Compounds; Oxonic Acid; Tegafur; Thrombocytopenia; Treatment Outcome | 2013 |
Efficacy of S-1 plus nedaplatin compared to standard second-line chemotherapy in EGFR-negative lung adenocarcinoma after failure of first-line chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Drug Combinations; Drug Therapy; ErbB Receptors; Female; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Mutation; Nausea; Neoplasm Staging; Organoplatinum Compounds; Oxonic Acid; Tegafur; Treatment Failure; Treatment Outcome; Vomiting | 2014 |
Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Docetaxel; Drug Combinations; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Oxonic Acid; Taxoids; Tegafur; Treatment Outcome | 2016 |
IMRT combined with S-1 concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a prospective phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Oxonic Acid; Paclitaxel; Prognosis; Prospective Studies; Radiotherapy, Intensity-Modulated; Survival Rate; Tegafur; Young Adult | 2019 |
22 other study(ies) available for tegafur and nedaplatin
Article | Year |
---|---|
[Neoadjuvant chemotherapy with nedaplatin and UFT for oral squamous cell carcinomas].
Topics: Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Nausea; Neoadjuvant Therapy; Organoplatinum Compounds; Preoperative Care; Tegafur; Uracil | 2003 |
[Nedaplatin for recurrent cancer of the head and neck].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Organoplatinum Compounds; Survival Rate; Tegafur; Uracil | 2004 |
[Pilot study of concomitant TS-1/CDGP radiotherapy for esophageal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Esophageal Neoplasms; Female; Humans; Male; Organoplatinum Compounds; Oxonic Acid; Pilot Projects; Pyridines; Quality of Life; Survival Rate; Tegafur | 2005 |
[Combination therapy with TS-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Drug Combinations; Fluorouracil; Head and Neck Neoplasms; Humans; Organoplatinum Compounds; Oxonic Acid; Pyridines; Taxoids; Tegafur | 2005 |
[Nedaplatin (NDP)-combination therapy (NDP/5-FU,NDP/S-1) for oral cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Mouth Neoplasms; Nausea; Organoplatinum Compounds; Oxonic Acid; Tegafur; Thrombocytopenia; Vomiting, Anticipatory | 2007 |
[A case of primary unknown cancer responding to CDGP/S-1].
Topics: Aged; Biopsy; Drug Combinations; Female; Humans; Neoplasms, Unknown Primary; Organoplatinum Compounds; Oxonic Acid; Positron-Emission Tomography; Tegafur; Ultrasonography | 2008 |
[Effective combination chemotherapy with gemcitabine hydrochloride, S-1 and nedaplatin for recurrent pancreatic cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Deoxycytidine; Drug Combinations; Gemcitabine; Humans; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxonic Acid; Pancreatic Neoplasms; Recurrence; Tegafur; Tomography, X-Ray Computed | 2008 |
[Nedaplatin combined with tegafur in the treatment for advanced esophageal cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Remission Induction; Survival Rate; Tegafur; Vomiting | 2008 |
[The effectiveness of concomitant radiotherapy with S-1 and nedaplatin for tongue cancer].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxonic Acid; Survival Rate; Tegafur; Tongue Neoplasms | 2009 |
[Effectiveness of concomitant therapy with S-1, nedaplatin, and radiation for laryngeal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Female; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxonic Acid; Survival Rate; Tegafur; Voice Quality | 2010 |
[Effectiveness of simultaneous combination therapy using S-1 and nedaplatin/radiation (SN therapy) for 4 cases of maxillary cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Humans; Male; Maxillary Neoplasms; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxonic Acid; Tegafur; Tomography, X-Ray Computed | 2010 |
[Effects of concurrent S-1, nedaplatin/radiation therapy for 5 cases of head and neck cancer with esophageal carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Esophageal Neoplasms; Fatal Outcome; Head and Neck Neoplasms; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxonic Acid; Tegafur | 2010 |
[Effectiveness of simultaneous combination therapy using S-1, nedaplatin and radiotherapy for 7 cases of oropharynx cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Humans; Male; Middle Aged; Organoplatinum Compounds; Oropharyngeal Neoplasms; Oxonic Acid; Tegafur | 2010 |
[Efficacy of concomitant therapy with S-1, CDGP, and radiation for laryngeal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Combinations; Female; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxonic Acid; Survival Rate; Tegafur | 2010 |
Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Combinations; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxonic Acid; Radiotherapy; Survival Rate; Tegafur; Treatment Outcome | 2011 |
[Efficacy of concurrent chemoradiotherapy with S-1 plus nedaplatin for hypopharyngeal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxonic Acid; Tegafur | 2011 |
[A case of hypopharyngeal cancer successfully treated with concurrent S-1, nedaplatin and radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Humans; Hypopharyngeal Neoplasms; Male; Organoplatinum Compounds; Oxonic Acid; Tegafur; Tomography, X-Ray Computed | 2011 |
[Laryngeal cancer treatment outcomes in our department].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxonic Acid; Survival Rate; Tegafur; Treatment Outcome | 2011 |
Salvage radiation therapy and chemoradiation therapy for postoperative locoregional recurrence of esophageal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinosarcoma; Chemoradiotherapy; Cisplatin; Cohort Studies; Drug Combinations; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxonic Acid; Pyridines; Radiotherapy; Retrospective Studies; Salvage Therapy; Survival Rate; Tegafur; Treatment Outcome | 2014 |
Clinical outcomes of nedaplatin and S-1 treatment with concurrent radiotherapy in advanced head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxonic Acid; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tegafur; Treatment Outcome | 2015 |
Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Drug Administration Schedule; Drug Combinations; Esophageal Neoplasms; Female; Fluorouracil; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Organoplatinum Compounds; Oxonic Acid; Retrospective Studies; Salvage Therapy; Tegafur | 2016 |
Long-term efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Organoplatinum Compounds; Oxonic Acid; Pharyngeal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Tegafur; Treatment Outcome | 2019 |